Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Coronavirus Disease (Covid-19): 10 Questions and Discussion Points for Diabetes and Covid-19 Publisher



Ebrahimpur M1 ; Payab M2 ; Sani MP3 ; Larijani B4
Authors

Source: Frontiers in Emergency Medicine Published:2021


Abstract

The COVID-19 pandemic is now an international concern. COVID-19 is first reported in Wuhan, China on 31 December 2019 and affects different people in different ways. Evidence suggests that people with underlying disease are at higher risk for more severe disease. People with diabetes are not only more likely than the general population to have COVID-19 but also they are among those high-risk categories that can have serious illness if they get the virus. © 2021 Tehran University of Medical Sciences.
Related Docs
View other Related Docs
1. Association Between Cardiometabolic Risk Factors and Covid-19 Susceptibility, Severity and Mortality: A Review, Journal of Diabetes and Metabolic Disorders (2021)
2. Prediction of In-Hospital Mortality Rate in Covid-19 Patients With Diabetes Mellitus Using Machine Learning Methods, Journal of Diabetes and Metabolic Disorders (2023)
3. Changes in Clinic Visits and Diabetes and Metabolic Control in Patients With Type 2 Diabetes During Covid-19 Pandemic: A Real World Evidence, Primary Care Diabetes (2023)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (3)
Moloud Payab (2)
Other Related Docs
4. Risk Indicators Associated With In-Hospital Mortality and Severity in Patients With Diabetes Mellitus and Confirmed or Clinically Suspected Covid-19, Journal of Diabetes and Metabolic Disorders (2021)
5. Epidemiological Characteristics of Patients With Covid-19 in Southwest of Iran From February 19 to June 20, 2020, Medical Journal of the Islamic Republic of Iran (2021)
6. Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the Covid-19 Pandemic: A Review of Current Literature, Advances in Therapy (2020)
7. Clinical Characteristics and Outcome of Hospitalized Covid-19 Patients With Diabetes: A Single-Center, Retrospective Study in Iran, Diabetes Research and Clinical Practice (2020)
8. Risk Factors Affecting the Mortality of Covid-19 Patients: Impacts of Modifiable Factors, Iranian Journal of Health and Environment (2021)
9. Tests With Proven Value in Diagnosis of Covid-19, Iranian Journal of Microbiology (2020)
10. Pediatric Endocrinopathies Related to Covid-19: An Update, World Journal of Pediatrics (2023)
11. Covid-19-Specific Worries Among People With Type 2 Diabetes Following the Continuation of the Pandemic and Occurrence of Multiple Waves of Covid-19 in Iran, Journal of Diabetes and Metabolic Disorders (2022)
12. The Epidemiologic Aspects of Covid-19 Outbreak: Spreading Beyond Expectations, Advances in Experimental Medicine and Biology (2021)
13. Late Complications of Covid-19; a Systematic Review of Current Evidence, Archives of Academic Emergency Medicine (2020)
14. Factors Associated With Covid-19 Morbidity and Mortality: A Narrative Review, Journal of Iranian Medical Council (2020)
15. Sars-Cov-2 and Covid-19, Evidence From a Literature Review: Review Article, Tehran University Medical Journal (2021)
16. The Future Effects of Covid-19 on the Health System: Applying the Futures Wheel Method, Medical Journal of the Islamic Republic of Iran (2022)
17. Risk Factors for Mortality in Patients With Coronavirus Disease 2019 (Covid-19) Infection: A Systematic Review and Meta-Analysis of Observational Studies, Aging Male (2021)
18. Dissection of Non-Pharmaceutical Interventions Implemented by Iran, South Korea, and Turkey in the Fight Against Covid-19 Pandemic, Journal of Diabetes and Metabolic Disorders (2021)
19. Immune Mechanisms in the Pathogenesis of Coronavirus Disease 2019, Journal of Cellular and Molecular Anesthesia (2022)
20. Experiences From the Management of Covid-19 Pandemic in a Nursing Home in Iran (March–April, 2020), Journal of Diabetes and Metabolic Disorders (2022)